Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,590 | 314 | 93.5% |
| Education | $316.90 | 16 | 6.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $537.86 | 34 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $445.68 | 31 | $0 (2019) |
| PFIZER INC. | $440.74 | 39 | $0 (2023) |
| Mannkind Corporation | $418.68 | 5 | $0 (2017) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $405.58 | 22 | $0 (2024) |
| Novo Nordisk Inc | $334.30 | 37 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $297.90 | 24 | $0 (2019) |
| SANOFI-AVENTIS U.S. LLC | $277.47 | 20 | $0 (2019) |
| Astellas Pharma US Inc | $195.40 | 9 | $0 (2023) |
| GlaxoSmithKline, LLC. | $173.59 | 13 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $83.34 | 2 | iRhythm Technologies, Inc. ($56.24) |
| 2023 | $97.85 | 6 | Bard Peripheral Vascular, Inc. ($24.01) |
| 2022 | $25.26 | 2 | Bayer HealthCare Pharmaceuticals Inc. ($13.55) |
| 2020 | $128.63 | 3 | Boehringer Ingelheim Pharmaceuticals, Inc. ($96.10) |
| 2019 | $982.65 | 79 | Novo Nordisk Inc ($187.48) |
| 2018 | $1,461 | 108 | Amgen Inc. ($231.71) |
| 2017 | $2,128 | 130 | Mannkind Corporation ($418.68) |
All Payment Transactions
330 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/18/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $27.10 | General |
| Category: DIABETES | ||||||
| 09/19/2024 | iRhythm Technologies, Inc. | ZIO XT Patch (Device), Zio monitor | Food and Beverage | In-kind items and services | $56.24 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/11/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $16.81 | General |
| Category: Biological | ||||||
| 05/01/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.59 | General |
| Category: Cardio-renal | ||||||
| 03/14/2023 | PFIZER INC. | TRUMENBA (Biological), PREVNAR 20, COMIRNATY | Food and Beverage | In-kind items and services | $20.76 | General |
| Category: VACCINES | ||||||
| 01/27/2023 | Bard Peripheral Vascular, Inc. | LUTONIX Drug Coated Balloon (Device) | Food and Beverage | In-kind items and services | $24.01 | General |
| Category: Vascular/Oncology | ||||||
| 01/27/2023 | Inari Medical, Inc. | FLOWTRIEVER CATHETER, S (Device), CT THROMBECTOMY SYSTEM KIT | Food and Beverage | In-kind items and services | $17.89 | General |
| Category: VTE | ||||||
| 01/20/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Education | In-kind items and services | $0.79 | General |
| Category: UROLOGY | ||||||
| 10/07/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $13.55 | General |
| Category: Cardio-renal | ||||||
| 06/02/2022 | Lilly USA, LLC | — | Education | In-kind items and services | $11.71 | General |
| 09/10/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Education | In-kind items and services | $96.10 | General |
| Category: DIABETES | ||||||
| 03/06/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $15.94 | General |
| Category: Diabetes | ||||||
| 02/07/2020 | PFIZER INC. | COLOGUARD (Device) | Food and Beverage | In-kind items and services | $16.59 | General |
| Category: GASTROINTESTINAL | ||||||
| 10/24/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $10.66 | General |
| Category: Diabetes | ||||||
| 09/20/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $3.82 | General |
| Category: Diabetes | ||||||
| 08/23/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $6.64 | General |
| Category: Diabetes | ||||||
| 08/20/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $4.70 | General |
| Category: Diabetes | ||||||
| 06/28/2019 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Food and Beverage | In-kind items and services | $16.64 | General |
| Category: Respiratory | ||||||
| 06/28/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $2.53 | General |
| Category: Diabetes | ||||||
| 06/25/2019 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Drug), SOLIQUA 100/33 | Food and Beverage | In-kind items and services | $13.38 | General |
| Category: DIABETES | ||||||
| 06/24/2019 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $22.89 | General |
| Category: Bone Health | ||||||
| 06/24/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $14.48 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/21/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $2.25 | General |
| Category: Diabetes | ||||||
| 06/18/2019 | Grifols USA, LLC | Prolastin-C (Biological) | Food and Beverage | In-kind items and services | $13.41 | General |
| Category: Pulmonology | ||||||
| 06/17/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.78 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 1 | 11 | 11 | $2,057 | $164.48 |
| 2021 | 20 | 1,430 | 1,802 | $145,731 | $23,393 |
| 2020 | 56 | 6,400 | 14,190 | $1.3M | $260,557 |
All Medicare Procedures & Services
77 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 93971 | Ultrasound study of one arm or leg veins with compression and maneuvers | Facility | 2022 | 11 | 11 | $2,057 | $164.48 | 8.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 270 | 323 | $50,065 | $7,263 | 14.5% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 83 | 103 | $11,855 | $4,328 | 36.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 71 | 72 | $14,184 | $2,432 | 17.1% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2021 | 178 | 180 | $13,500 | $1,874 | 13.9% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2021 | 129 | 129 | $14,835 | $1,706 | 11.5% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2021 | 129 | 135 | $5,940 | $1,037 | 17.5% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2021 | 15 | 15 | $2,310 | $769.65 | 33.3% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 79 | 79 | $6,162 | $767.09 | 12.4% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2021 | 39 | 41 | $4,551 | $688.80 | 15.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 200 | 221 | $5,083 | $661.06 | 13.0% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2021 | 15 | 16 | $1,024 | $461.67 | 45.1% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2021 | 37 | 39 | $3,705 | $351.78 | 9.5% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2021 | 17 | 17 | $2,193 | $328.27 | 15.0% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 41 | 54 | $4,298 | $254.68 | 5.9% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2021 | 39 | 50 | $1,400 | $158.50 | 11.3% |
| 83735 | Magnesium level | Office | 2021 | 17 | 17 | $731.00 | $113.90 | 15.6% |
| 85610 | Blood test, clotting time | Office | 2021 | 15 | 26 | $988.00 | $111.54 | 11.3% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2021 | 11 | 11 | $451.00 | $68.53 | 15.2% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2021 | 28 | 240 | $960.00 | $12.24 | 1.3% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2021 | 17 | 34 | $1,496 | $6.30 | 0.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 746 | 2,377 | $361,625 | $99,066 | 27.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 277 | 402 | $78,330 | $30,641 | 39.1% |
| 78452 | Nuclear medicine study of vessels of heart using drugs or exercise multiple studies | Office | 2020 | 81 | 82 | $123,935 | $22,348 | 18.0% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2020 | 69 | 280 | $61,040 | $12,782 | 20.9% |
About Dr. Samuel Stone, MD
Dr. Samuel Stone, MD is a Family Medicine healthcare provider based in Chester, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1063426955.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Samuel Stone, MD has received a total of $4,907 in payments from pharmaceutical and medical device companies, with $83.34 received in 2024. These payments were reported across 330 transactions from 44 companies. The most common payment nature is "Food and Beverage" ($4,590).
As a Medicare-enrolled provider, Stone has provided services to 7,841 Medicare beneficiaries, totaling 16,003 services with total Medicare billing of $284,114. Data is available for 3 years (2020–2022), covering 77 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Chester, SC
- Active Since 07/28/2006
- Last Updated 10/14/2020
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1063426955
Products in Payments
- AFREZZA (Drug) $418.68
- Prolia (Biological) $355.90
- ENTRESTO (Drug) $297.90
- JARDIANCE (Drug) $213.50
- Ozempic (Drug) $178.37
- BYDUREON (Drug) $131.32
- TRADJENTA (Drug) $115.48
- CHANTIX (Drug) $114.53
- SYMBICORT (Drug) $109.63
- Amitiza (Drug) $103.36
- ANORO (Drug) $99.70
- FARXIGA (Drug) $98.15
- Prolastin-C Liquid (Biological) $95.34
- SOLIQUA (Drug) $94.90
- TOUJEO (Drug) $93.97
- VIAGRA (Drug) $89.67
- Repatha (Biological) $85.46
- EUCRISA (Drug) $74.57
- PRALUENT (Drug) $73.03
- LYRICA (Drug) $70.29
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Chester
Andrew Rose, M.d, M.D
Family Medicine — Payments: $11,868
Ciro Attardo, M.d, M.D
Family Medicine — Payments: $6,971
Mrs. Megan Caravas, Pa-C, PA-C
Family Medicine — Payments: $5,162
Douglas Beckwith, Md, MD
Family Medicine — Payments: $3,999
Thomas Yuen, Md, MD
Family Medicine — Payments: $3,566
James Krieg, Md, MD
Family Medicine — Payments: $3,323